The Latest Breaking News from CoDiagnostics Inc

Co-Diagnostics Stock Surges As Q1 Results Surpass Street Expectations

Co-Diagnostics Inc (NASDAQ: CODX) reported first-quarter revenue growth of 13.4% year-over-year to $22.7 million, beating the consensus of $20.17 million.

Benzinga · May 12, 2022